A Single-arm, Multicenter, Phase Ⅱ Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer Who Have Received at Least One Line of Therapy
Latest Information Update: 24 Mar 2023
At a glance
- Drugs Docetaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
Most Recent Events
- 20 Mar 2023 Status changed from not yet recruiting to recruiting.
- 16 Nov 2022 New trial record